# The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

> **NCT05173493** · — · COMPLETED · sponsor: **Shandong University** · enrollment: 670 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Amoxicillin,Furazolidone
- **DRUG:** Amoxicillin,Levofloxacin
- **DRUG:** Tetracycline,Furazolidone

## Key facts

- **NCT ID:** NCT05173493
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-30
- **Primary completion:** 2023-02-10
- **Final completion:** 2023-02-10
- **Target enrollment:** 670 (ACTUAL)
- **Last updated:** 2023-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05173493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05173493, "The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05173493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*